Digitalisierung der Supply Chain, Anpassung Ihres Unternehmens an neue Entwicklungen

Wir helfen Life-Science-Unternehmen bei Planung, Management und bei Lieferung ihrer Verpackungen, Marketingkommunikationsmaterialien und digitalen Assets sowie bei der Optimierung ihrer digitalen Supply Chain.

Wir unterstützen Life Science-Unternehmen bei der Konzeption, Verwaltung und Lieferung von Verpackungsgrafiken, Marken und digitalen Assets


Sechs Lösungen, ein Team und eine digitalisierte Supply Chain



Mit unseren sechs Kernbereichen verwirklichen wir eine gemeinsame Vision: erstklassige Supply-Chain-Lösungen an die Life-Science-Industrie zu liefern. Jedes unserer Teams zeichnet sich durch spezielles Know-how in den Bereichen Creative, Marketing, Packaging Artwork und Labelling sowie Software aus – und zusammen sind unsere Teams unschlagbar. Egal ob Sie eine, zwei oder alle unsere Lösungen nutzen, werden Sie feststellen, dass unsere geballte Fachkompetenz und unser gesamtes Wissen in alle unsere Lösungen einfließen – was wir liefern und wie wir es liefern.

Qualität garantiert


Patientensicherheit und Risikominderung stehen bei uns im Vordergrund: Unsere Unternehmenskultur, GMP / GAMP-konforme Prozesse und die Entwicklung unserer Qualitätsmanagementsysteme orientieren sich an diesem Grundsatz. Alle von Perigord sowohl regional als auch global erbrachten Dienstleistungen sind nach ISO 9001: 2015, PS 9000: 2016 zertifiziert und entsprechen 21 CFR Part 11 und Eudralex Volume 4, Annex 11. Über diese globalen Standards hinaus wird Perigord fortlaufend auditiert Grundlage unserer Kunden: Perigord wurde 2018 von 15 der 20 weltweit führenden Life-Science-Unternehmen geprüft, die alle Prüfungen mit Auszeichnung bestanden haben.
Weiterlesen

Mit unseren Lösungen können Life-Science-Unternehmen ihre Supply Chain digitalisieren und integrieren

Fortschritte in Automatisierung, Digitalisierung, künstlicher Intelligenz und Analysetools revolutionieren die Art und Weise, in der Unternehmen und Industrien arbeiten. Durch innovative Grundlagentechnologien entwickeln sich Arbeitswelt und globale Geschäftsabläufe stetig weiter. Perigord hat die Entwicklung, Integration und Einführung dieser Technologien in der Life-Science-Branche wegweisend vorangetrieben.

Wir bringen die reale Welt und die digitale Welt zusammen – angesichts der rasanten Entwicklung der digitalen Möglichkeiten ist eine gut vernetzte Supply Chain immer häufiger mitentscheidend für den Geschäftserfolg. Mit den entsprechenden Grundlagentechnologien können Life-Science-Unternehmen weltweit Änderungen umsetzen und managen, die Einhaltung von Standardprozessen sicherstellen, die Effizienz steigern, Markteinführungen beschleunigen und vor allem ihre Kosten senken.

„Aussagekräftige Daten in Echtzeit zu erfassen und auszutauschen, bringt Unternehmen und Kunden enger zusammen.“
Die moderne Lieferkette muss mit dem digitalen Verbraucher von Morgen vernetzt sein. Perigord arbeitet mit den führenden Life-Science-Unternehmen der Welt zusammen und ist in der einzigartigen Position, mithilfe seiner Grundlagentechnologien Echtzeitlösungen an die Branche zu liefern, die nicht nur die kompromisslose Einhaltung geltender Rechtsvorschriften und hohe Wertschöpfung garantieren, sondern den Kunden auch dabei helfen, von neuen Möglichkeiten für die Supply Chain zu profitieren.

Garantierte Qualität


Patientensicherheit und Risikominimierung sind das Fundament unserer Kultur der operativen Exzellenz. Die von uns eingesetzten GMP/GAMP-konformen Prozesse und unser maßgeschneidertes Qualitätsmanagementsystem sind exakt darauf ausgerichtet.

Alle von Perigord erbrachten Dienstleistungen, sowohl regional als auch global, sind nach ISO 9001:2015, PS 9000:2016 zertifiziert und entsprechen 21 CFR Part 11 sowie Eudralex Volume 4, Annex 11. Über diese globalen Standards hinaus wird Perigord regelmäßig von seinen Kunden auditiert. Im Jahr 2018 wurden wir von 15 der 20 weltweit führenden Life-Science-Unternehmen geprüft, wobei alle Audits mit Bravour bestanden wurden.
Lesen Sie weiter

Über uns


Wir bedienen die globale Life-Science-Branche mit Hauptsitz in Dublin, Irland, und haben vier Zentren für Kreativ- und Verpackungskompetenz in Dublin, Irland, Waldkirch, Deutschland, Connecticut, USA und Hyderabad, Indien sowie regionale Vertriebs- und Account-Management-Supportbüros in Massachusetts, New York und Kalifornien in den USA und Christchurch, Neuseeland.
Weiterlesen

Global Centres of Creative and Packaging Excellence


+40

Jahre Erfahrung

+350

Fachkräfte weltweit

100

Bediente Märkte

7%

Investition in Forschung und Entwicklung jährlich
Über unsere Global Centres of Creative and Packaging Excellence in Europa, Asien und Nordamerika bedienen wir die gesamte Life-Science-Branche. Wir unterstützen unsere Kunden dabei, ihre Produkte unter Einhaltung sämtlicher Vorschriften und so kreativ wie möglich auf den Markt zu bringen. Dabei stellen wir die Patientensicherheit in den Mittelpunkt unserer Tätigkeit und richten unsere Dienstleistungen global und regional an den Markt- und Expansionsanforderungen unserer Kunden aus.
 
Mit unseren Kunden verbinden uns langfristige, partnerschaftliche Geschäftsbeziehungen, die auf unserer makellosen Erfolgsbilanz basieren, mit der wir die Erwartungen unserer Kunden erfüllen und übertreffen. Zu diesem Zweck nutzen wir einen kontinuierlichen Analyse-, Verbesserungs- und Weiterentwicklungsprozess.
Lesen Sie weiter

Neuesten Nachrichten


von Adriana Medina 23. April 2025
Designed specifically for the Life Science Industry, this version of our GLAMS AMS solution ensures that Perigord maintains its leadership position as the go-to provider of the world's leading Life Science and Pharmaceutical Artwork Management Platform. Dublin, Ireland – Perigord is proud to announce the launch of GLAMS AMS 6 , the latest evolution of its Artwork Management System (AMS) built specifically for the Life Science industry. GLAMS AMS 6 is a cornerstone of our Global Life Sciences Automation Management System . Featuring the most advanced and cutting-edge capabilities, GLAMS AMS 6 helps Life Science companies address their most pressing challenges and needs in artwork creation, approval, and compliance within the industry today. With the adoption of GLAMS AMS 6, our clients can accelerate efficiency across the artwork production and approval process, significantly reducing their time-to-market. With the GLAMS AMS 6 solution, Life Science organisations can optimise processes and manage artwork production globally in a seamless and unified system. Key GLAMS AMS 6 Enhancements Include: State-of-the-Art UX Upgrades: Intuitive interface designed for faster, more accessible, and easier navigation and searching across the platform, now complemented by an AI assistant tool for improved user support. Faster Response Times: Enhanced performance for quicker processing and a smoother user experience. Strengthened BI Reporting: Advanced reporting capabilities providing comprehensive insights into every stage of the artwork lifecycle. Expanded Stamping Capabilities: Flexible, configurable options for document approval stamps to ensure clarity and compliance. Upgraded Linked Workflow Creation and Integration: Seamless creation and management of complex hierarchical workflows for more accurate project tracking and efficiency. File View and Navigation without Download: Enables quicker, more efficient interaction with artwork files, reducing the need for downloads. Real-Time Task Dependency Refinements: Improved visibility into task interdependencies, promoting better collaboration and reducing bottlenecks. Automated Decision-Based Workflow Advancements: Automation of workflow paths based on data and decisions made as the process progresses, increasing efficiency and accuracy in the critical path without manual intervention. Integrated Subscription-Based Notification Centre: Real-time, on-screen notifications allowing more efficient interaction with workflows. Enhanced User Permission Administration: Offering efficiencies to handle whole-user base access permissions in just a few clicks. GLAMS AMS 6 builds upon the foundation of previous releases while introducing new features that set it apart from other AMS solutions. GLAMS AMS 6 helps companies enhance productivity, reduce artwork approval time, and maintain regulatory compliance – ensuring a faster and more efficient time-to-market for critical products. " The launch of GLAMS AMS 6 is a major milestone for us, further solidifying our position as the industry’s leading Artwork Management solution provider ,” says Suzanne Ivory, Chief Operations Officer, Perigord . “ Through close collaboration with some of the world’s top Pharmaceutical and Life Science organisations, we've developed a solution that makes workflows more efficient, reduces delays in packaging development, and helps teams manage and approve artwork with speed and full compliance. " Sam Cole, Director of Client Services, Perigord , adds, “ The new enhancements in GLAMS AMS 6 have been designed to offer a truly automated, scalable, and compliant solution that integrates seamlessly with existing systems, optimising key processes at every stage of the packaging and labelling workflow. These improvements are a direct result of our ongoing efforts to support Life Science organisations in managing more complex global regulatory requirements while improving operational efficiency. ” About GLAMS AMS GLAMS AMS is the only Artwork Management System developed specifically for the Life Science industry, addressing the unique challenges associated with artwork creation, approvals, and regulatory compliance. By leveraging automated workflows, advanced integration with existing business systems, and powerful reporting tools, GLAMS AMS helps clients in the Life Sciences industry minimise risk, streamline approval cycles, and accelerate product launches across multiple regulatory regions simultaneously. Available now, GLAMS AMS 6 is ready to help businesses evolve their artwork and labelling management with greater speed, security, and compliance. Request a demo at: www.GLAMS.com For more information contact your GLAMS Account Manager or: Mark Ennis Global Business Development Director mark.ennis@perigord-as.com Perigord Life Science Solutions Unit 1, Lyncon Court IDA Business & Technology Park Snugborough Road, Blanchardstown Dublin, D15 N283, Ireland mediarelations@perigord-as.com Tel: +353 1 440 3222 www.GLAMS.com
von Gary Orr 1. April 2025
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
von Adriana Medina 1. April 2025
Best Practice White Paper for Remote Auditing in a GMP Environment Since 2020, auditing as we know it has changed. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.
von Gary Orr 1. April 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper

Neuesten Nachrichten


von Adriana Medina 23. April 2025
Designed specifically for the Life Science Industry, this version of our GLAMS AMS solution ensures that Perigord maintains its leadership position as the go-to provider of the world's leading Life Science and Pharmaceutical Artwork Management Platform. Dublin, Ireland – Perigord is proud to announce the launch of GLAMS AMS 6 , the latest evolution of its Artwork Management System (AMS) built specifically for the Life Science industry. GLAMS AMS 6 is a cornerstone of our Global Life Sciences Automation Management System . Featuring the most advanced and cutting-edge capabilities, GLAMS AMS 6 helps Life Science companies address their most pressing challenges and needs in artwork creation, approval, and compliance within the industry today. With the adoption of GLAMS AMS 6, our clients can accelerate efficiency across the artwork production and approval process, significantly reducing their time-to-market. With the GLAMS AMS 6 solution, Life Science organisations can optimise processes and manage artwork production globally in a seamless and unified system. Key GLAMS AMS 6 Enhancements Include: State-of-the-Art UX Upgrades: Intuitive interface designed for faster, more accessible, and easier navigation and searching across the platform, now complemented by an AI assistant tool for improved user support. Faster Response Times: Enhanced performance for quicker processing and a smoother user experience. Strengthened BI Reporting: Advanced reporting capabilities providing comprehensive insights into every stage of the artwork lifecycle. Expanded Stamping Capabilities: Flexible, configurable options for document approval stamps to ensure clarity and compliance. Upgraded Linked Workflow Creation and Integration: Seamless creation and management of complex hierarchical workflows for more accurate project tracking and efficiency. File View and Navigation without Download: Enables quicker, more efficient interaction with artwork files, reducing the need for downloads. Real-Time Task Dependency Refinements: Improved visibility into task interdependencies, promoting better collaboration and reducing bottlenecks. Automated Decision-Based Workflow Advancements: Automation of workflow paths based on data and decisions made as the process progresses, increasing efficiency and accuracy in the critical path without manual intervention. Integrated Subscription-Based Notification Centre: Real-time, on-screen notifications allowing more efficient interaction with workflows. Enhanced User Permission Administration: Offering efficiencies to handle whole-user base access permissions in just a few clicks. GLAMS AMS 6 builds upon the foundation of previous releases while introducing new features that set it apart from other AMS solutions. GLAMS AMS 6 helps companies enhance productivity, reduce artwork approval time, and maintain regulatory compliance – ensuring a faster and more efficient time-to-market for critical products. " The launch of GLAMS AMS 6 is a major milestone for us, further solidifying our position as the industry’s leading Artwork Management solution provider ,” says Suzanne Ivory, Chief Operations Officer, Perigord . “ Through close collaboration with some of the world’s top Pharmaceutical and Life Science organisations, we've developed a solution that makes workflows more efficient, reduces delays in packaging development, and helps teams manage and approve artwork with speed and full compliance. " Sam Cole, Director of Client Services, Perigord , adds, “ The new enhancements in GLAMS AMS 6 have been designed to offer a truly automated, scalable, and compliant solution that integrates seamlessly with existing systems, optimising key processes at every stage of the packaging and labelling workflow. These improvements are a direct result of our ongoing efforts to support Life Science organisations in managing more complex global regulatory requirements while improving operational efficiency. ” About GLAMS AMS GLAMS AMS is the only Artwork Management System developed specifically for the Life Science industry, addressing the unique challenges associated with artwork creation, approvals, and regulatory compliance. By leveraging automated workflows, advanced integration with existing business systems, and powerful reporting tools, GLAMS AMS helps clients in the Life Sciences industry minimise risk, streamline approval cycles, and accelerate product launches across multiple regulatory regions simultaneously. Available now, GLAMS AMS 6 is ready to help businesses evolve their artwork and labelling management with greater speed, security, and compliance. Request a demo at: www.GLAMS.com For more information contact your GLAMS Account Manager or: Mark Ennis Global Business Development Director mark.ennis@perigord-as.com Perigord Life Science Solutions Unit 1, Lyncon Court IDA Business & Technology Park Snugborough Road, Blanchardstown Dublin, D15 N283, Ireland mediarelations@perigord-as.com Tel: +353 1 440 3222 www.GLAMS.com
von Gary Orr 1. April 2025
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
von Adriana Medina 1. April 2025
Best Practice White Paper for Remote Auditing in a GMP Environment Since 2020, auditing as we know it has changed. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.
von Gary Orr 1. April 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper

Kommende Veranstaltungen